Yash Chemex Ltd. Reports Q1 FY27 Results

Consolidated revenue from operations for Q1 ended June 30, 2026, stood at Rs 1,718.40 lakh, a decrease from Rs 3,010.46 lakh in Q1 FY26.

Net profit for Q1 FY27 increased to Rs 104.18 lakh from Rs 85.80 lakh in Q1 FY26.

Reader Takeaway: Profitability improved year-over-year despite a significant revenue drop; auditor appointments confirmed.

What just happened

Yash Chemex Ltd. announced its un-audited financial results for the first quarter ended June 30, 2026. The company's consolidated revenue from operations declined by approximately 43% to Rs 1,718.40 lakh from Rs 3,010.46 lakh in the same period last year. However, the consolidated net profit saw an increase, rising to Rs 104.18 lakh compared to Rs 85.80 lakh in the prior year's first quarter. The company also reported a turnaround from a net loss of Rs 43.95 lakh in the preceding March 2026 quarter to a profit in the June 2026 quarter.

Why this matters

The results indicate resilience in profitability despite a challenging revenue environment. The profit increase suggests efficient cost management or improved margins on its existing sales. For investors, this means the company is managing to protect its bottom line even as top-line sales shrink, which is a positive sign of operational efficiency. The appointment of new auditors also signals a focus on governance and future stability.

The backstory

In the previous financial year, Yash Chemex had reported revenues of Rs 3,010.46 lakh for the first quarter of FY26. This period saw a net profit of Rs 85.80 lakh. The preceding quarter, ending March 31, 2026, had reported a consolidated net loss of Rs 43.95 lakh. The company is now moving towards strengthening its audit framework with new appointments.

What changes now

Following board approval, M/s N. H. Desai & Co. will serve as the Internal Auditor for FY 2026-27. More significantly, M/s TRS & Associates are proposed as Statutory Auditors for a five-year term (FY 2026-27 to FY 2030-31), pending shareholder approval at the upcoming Annual General Meeting (AGM).

Risks to watch

The primary concern is the substantial 43% year-over-year decline in consolidated revenue. Sustaining profitability without a recovery in sales could be challenging in the long term. Additionally, the appointment of the statutory auditors requires shareholder approval at the AGM scheduled for September 30, 2026.

Peer comparison

Information on specific peers' Q1 FY27 performance and their auditor appointments is not available in this filing. Investors may need to look at broader chemical industry trends and competitors' recent financial disclosures for a comprehensive comparison.

Context metrics (time-bound)

• Revenue (Q1 FY27): Rs 1,718.40 lakh (vs Rs 3,010.46 lakh in Q1 FY26)
• Net Profit (Q1 FY27): Rs 104.18 lakh (vs Rs 85.80 lakh in Q1 FY26)
• Profitability Turnaround: Moved from Rs 43.95 lakh loss (Q4 FY26) to Rs 104.18 lakh profit (Q1 FY27).
• AGM Date: September 30, 2026

What to track next

Investors should closely watch the company's performance in the upcoming quarters to see if the revenue decline is arrested and if profitability can be sustained. The outcome of the AGM on September 30, 2026, regarding the appointment of the statutory auditors will also be important.